FDA Adverse Event Malfunction Summary report: N

COBAS 6000 C (501) MODULE

MDR report key: 20260712 · Received September 19, 2024

Report

Report Number
1823260-2024-02710
Event Type
Malfunction
Date Received
September 19, 2024
Date of Event
August 27, 2024
Report Date
November 8, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
UDI-DI
08430215011546
PMA / PMN Number
K060373
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

SECTIONS D1-D4, G1, AND G4 WERE UPDATED. THE FIELD SERVICE REPRESENTATIVE FOUND THE RINSE TUBING WAS CRACKED. THE RINSE TUBING WAS ADJUSTED TO RESOLVE THE LEAK. AFTER SERVICE, NO ISSUES WERE REPORTED BY THE CUSTOMER. THE INVESTIGATION DETERMINED THE SERVICE ACTIONS RESOLVED THE ISSUE.

Additional Manufacturer Narrative · 0

THE ANALYZER'S SERIAL NUMBER IS (B)(6). THE INVESTIGATION IS ONGOING.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE NA ELECTRODE RESULTS FOR 2 PATIENT SAMPLES ON A COBAS 6000 C (501) MODULE. PATIENT 1: (ID: (B)(6): THE INITIAL RESULT WAS 177 MMOL/L. THE REPEATED RESULT WAS 135 MMOL/L. PATIENT 2: (ID: (B)(6): THE INITIAL RESULT WAS 167 MMOL/L. THE REPEATED RESULT WAS 138 MMOL/L. THE QUESTIONABLE RESULTS WERE REPORTED OUTSIDE THE LABORATORY AND CORRECTED REPORTS WERE FILED. THE SAMPLES WERE REPEATED DUE TO FAILING DELTA CHECKS AND THE INITIAL RESULT FOR PATIENT 1 DID NOT MATCH THE PATIENT'S CLINICAL HISTORY. THE REPEATED RESULTS WERE OBTAINED ON ANOTHER ANALYZER AND WERE BELIEVED TO BE CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1431306 COBAS 6000 C (501) MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS ASKU 08430215011546

Patients

Seq Age Sex Outcome Treatment
1 81 YR Male PATIENT 1: ALBUTEROL| PATIENT 1: ASPIRIN| PATIENT 1: BRISDOL| PATIENT 1: CARVETILOL| PATIENT 1: DEXTROSE AND GLUCOSE| PATIENT 1: FLOMAX| PATIENT 1: HYDROCORTISONE| PATIENT 1: KETOROLAC| PATIENT 1: LEVANOX| PATIENT 1: LEVOTHYROXINE| PATIENT 1: LORAZEPAM| PATIENT 1: MAGNESIUM SULFATE| PATIENT 1: MENTHOL ZINC OXIDE TOPICAL OINTMENT| PATIENT 1: NORFLEX INJECTABLE| PATIENT 1: PEPSID| PATIENT 1: PLAVIX| PATIENT 1: POTASSIUM CHLORIDE| PATIENT 1: POTASSIUM PHOSPHATE/SODIUM PHOSPHATE| PATIENT 1: SODIUM CHLORIDE| PATIENT 1: SUROSEMIDE| PATIENT 2: BENADRYL INJECTION| PATIENT 2: LABETALOL| PATIENT 2: NORMAL SALINE 1000ML INFUSION| PATIENT 2: PROCHLORTERAZINE INJECTION